Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN27929536
ISRCTN27929536
Completed
Not Applicable

The ACTIVE study: a multicentre randomised, double-blind, controlled trial of laparoscopic versus open surgery for acute cholecystitis in adults

Italian Polispecialistic Society of Young Surgeons (Italy)0 sites144 target enrollmentDecember 21, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Italian Polispecialistic Society of Young Surgeons (Italy)
Enrollment
144
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 21, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Italian Polispecialistic Society of Young Surgeons (Italy)

Eligibility Criteria

Inclusion Criteria

  • •1\. Adult patients (more than 18 years)
  • •2\. Clinical (pain, fever more than 37\.5°C, White Blood Cells (WBC) more than 10,000/microL), and ultrasound evidence of cholecystitis
  • •3\. American Surgical Association (ASA) grade I to III patients
  • •4\. Informed consent
  • •5\. Less than 72 hours from onset

Exclusion Criteria

  • •1\. Informed consent refusal
  • •2\. Choledocholithiasis
  • •3\. Generalised peritonitis
  • •4\. Previous abdominal surgical procedures
  • •5\. Patients with an intra\-operative findings of different pathology will be excluded from the study
  • •6\. Apache II score more than ten

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A randomised study of two schedules of radiotherapy or chemotherapy in elderly patients with high grade gliomaMalignant glioma, grade 3-4 or 4CancerMalignant neoplasm of brain
ISRCTN81470623ordic Clinical Brain Tumor Study group (Sweden)342
Active, not recruiting
Not Applicable
A research study to evaluate the effect of 3 different doses of a new medicine (glycopyrrolate) administered in combination with a licenced medicine (Foster®) in patients with uncontrolled asthmauncontrolled asthmaMedDRA version: 17.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2013-003043-36-DECHIESI FARMACEUTICI S.p.A220
Active, not recruiting
Not Applicable
A clinical trial to assess the most efficacious dose of bronchodilator, Glycopyrrolate, to add to the existing treatment (Foster®, Beclomethasone + Formoterol) for the development of a new triple therapy in a single aerosol for the treatment of patients suffering from severe COPD.
EUCTR2011-003588-31-PLChiesi Farmaceutici S.p.A.180
Active, not recruiting
Not Applicable
A research study to evaluate the effect of 3 different doses of a new medicine (glycopyrrolate) administered in combination with a licenced medicine (Foster®) in patients with uncontrolled asthmauncontrolled asthmaMedDRA version: 16.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2013-003043-36-GBCHIESI FARMACEUTICI S.p.A220
Active, not recruiting
Not Applicable
A clinical trial to assess the most efficacious dose of bronchodilator, Glycopyrrolate, to add to the existing treatment (Foster®, Beclomethasone + Formoterol) for the development of a new triple therapy in a single aerosol for the treatment of patients suffering from severe COPD.
EUCTR2011-003588-31-HUChiesi Farmaceutici S.p.A.180